Latest News
From the Journals
Most type 2 diabetes patients skipping metformin as first-line therapy
Claims data show that few people with type 2 diabetes start their blood sugar control regimen with metformin, even though the ADA recommends it as...
From the Journals
WHI hormone trials offer reassurance on long-term mortality risk
New data from the WHI trials suggest that the use of conjugated equine estrogens alone or with medroxyprogesterone acetate is safe for 5-7 years...
From the Journals
Metabolically healthy obese still at elevated cardiovascular risk
Fat is not benign, according to a U.K. study of 3.5 million people.
Feature
Absorb bioresorbable scaffold folds
Abbott is no longer marketing the Absorb bioresorbable scaffold, citing poor sales.
News from the FDA/CDC
Recent upturn seen in stroke death rate
Long-term decline ended in 2013; reasons for the reversal “are not clear.”
Feature
Florida health officials prepare for Hurricane Irma
State and local health officials prepare as Hurricane Irma edges closer to southern Florida.
Conference Coverage
Ivabradine cut mortality in HFrEF patients not on beta-blocker
BARCELONA – Secondary analysis of SHIFT trial suggests potential expanded role for heart failure agent.
Feature
Sen. Alexander seeks quick, passable steps to stabilize individual markets
State insurance commissioners give their views on how to achieve stability.
Feature
Hurricane Harvey tests Houston physicians’ mettle
Houston doctors gave their best as Hurricane Harvey gave their city its worst.
From the Journals
Statin use cuts risks in compensated cirrhosis
Hepatic decompensation and mortality dropped 46% in patients with compensated cirrhosis of any etiology.
Latest News
Medicare fee schedule: Proposed pay bump falls short of promise
CMS officials were not able to find adequate funding in so-called misvalued codes to back the increase promised by MACRA, as required by law,...